Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-17

Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Tamsulosin Hydrochloride in Children With Voiding Disorders [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics, safety and tolerability of tamsulosin hydrochloride in children with voiding disorders has completed, providing early…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamsulosin hydrochloride (tamsulosin hydrochloride)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Urination Disorders | Phase 1 | Status: COMPLETED